Breakdown | Dec 2024 | Dec 2023 | Dec 2022 |
---|---|---|---|
Income Statement | |||
Total Revenue | 48.49M | 35.84M | 20.01M |
Gross Profit | 17.74M | 12.65M | 7.74M |
EBITDA | -73.92M | 1.33M | -10.01M |
Net Income | -85.00M | -804.98K | -11.01M |
Balance Sheet | |||
Total Assets | 92.92M | 119.62M | 26.53M |
Cash, Cash Equivalents and Short-Term Investments | 3.65M | 3.03M | 3.91M |
Total Debt | 23.14M | 17.59M | 6.71M |
Total Liabilities | 56.51M | 47.25M | 50.67M |
Stockholders Equity | 36.40M | 72.62M | -25.30M |
Cash Flow | |||
Free Cash Flow | -10.30M | -1.68M | -1.04M |
Operating Cash Flow | -10.21M | -1.42M | -760.11K |
Investing Cash Flow | 947.95K | 252.74K | -2.36M |
Financing Cash Flow | 10.00M | 530.97K | 4.99M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
47 Neutral | 2.07M | >-0.01 | -44.99% | ― | 6.77% | 97.28% | |
45 Neutral | 4.10M | -0.10 | 0.00% | ― | -100.00% | 86.75% | |
38 Underperform | ― | -155.94% | ― | 35.08% | -10462.99% | ||
30 Underperform | 2.20M | -0.09 | 0.00% | ― | 0.00% | 74.27% | |
29 Underperform | 2.18M | -0.04 | 0.00% | ― | 0.00% | 98.25% | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% |
On June 30, 2025, TNL Mediagene announced the resignation of Ms. Takako Masai from its Board of Directors for personal reasons, with no disagreements with the company’s operations. Subsequently, Ms. Naoko Okumoto was appointed as an interim director effective July 1, 2025, bringing extensive experience in tech investment and cross-border business development. Her appointment is expected to enhance the company’s strategic insight and global perspective, pending shareholder approval at the upcoming annual meeting.
TNL Mediagene, a company involved in media and technology, has announced amendments to its ordinary share purchase agreement with Tumim Stone Capital LLC, originally dated November 25, 2024. On June 13, 2025, the amendments removed the requirement that the closing sale price of TNL Mediagene’s ordinary shares must be at least $1.00 per share. Following this amendment, TNL Mediagene issued a purchase notice to Tumim for 440,000 ordinary shares, expected to be issued around June 20, 2025. This strategic move aims to enhance the company’s financial flexibility and market positioning.